Archive for the 'SEC filings' Tag

Not quite two weeks ago, we passed the midpoint of 2011, marking a perfect opportunity to continue ignoring our New Year’s resolutions — and to check in on that marvel of modern investing, the Edgar database at the Securities and Exchange Commission. Edgar, of course, is the SEC’s ever-growing trove of corporate disclosures — as [...]

There’s usually a time in late February — invariably on a Friday — when the folks here at footnoted begin to wonder what the hell we’re doing as we stare at several hundred filings in our inbox. Just like the little Dutch Boy,  we often feel as if we’re trying to plug the hole in [...]

A lot of companies are jumping into M&A deals willingly, but that’s certainly not the case for Genzyme Corporation (GENZ), which is doing its best to fend off Sanofi-Aventis SA’s (SNY) $18.5 billion hostile takeover proposal – despite the buckets of cash that Genzyme’s executives would get in the process. On October 7, Genzyme issued a [...]